GENOME-WIDE CRISPR/CAS9 VIABILITY SCREEN TO UNCOVER MOLECULAR TARGETS THAT MODULATE THE SURVIVAL OF POLYCYSTIC KIDNEY DISEASE MUTANT CELLS
$334,999FY2021Defense Health AgencyDOD
Yale Univ
Investigators
View source on USAspending →GENOME-WIDE CRISPR/CAS9 VIABILITY SCREEN TO UNCOVER MOLECULAR TARGETS THAT MODULATE THE SURVIVAL OF POLYCYSTIC KIDNEY DISEASE MUTANT CELLS · GrantIndex